|
Obrecht owned pharmacies in Ames and Huxley, Iowa, for 40 years. Today he works part time at two rural, locally owned pharmacies.
"Insurance companies no longer pay for brand name drugs, in most cases, and if they do, the co-pay is higher," he says. "But pharmacists are required to inform patients that a generic is being substituted."
A generic drug often differs in color, taste, or shape. Companies must prove to FDA that it has the same bio availability as the brand and that it's absorbed into the body with no more than a 10% difference.
However, some generics may not be advisable for certain medical conditions. In these cases, small changes in dose and/or blood concentration could cause clinically important changes in how the drug works.
One such drug is Coumadin, a blood thinner. Switching to a generic could thin blood too much (causing bleeding) or not enough (raising the risk that a clot could form).
"It may not be advisable to switch to a generic," Obrecht says. "The body may react differently."
Similar concerns apply to certain cardiac, thyroid, or epilepsy drugs.
|